Subject: SGLT2 inhibitors
Subject: mechanism of action
Subject: heart failure
Year: 2023
Type: Article
Title: SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN HEART FAILURE
Author: Georgiev, Antonio
Author: Tonev, Jelena
Author: Jovanovski Srceva, Marija
Author: Nikolov, Igor
Author: Jankulovska, Anamarija
Author: Manev, Nikola
Author: Mitevski, Goran
Abstract: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are antidiabetic drugs whose therapeutic action has gone beyond diabetes and extended to the cardiovascular and renal systems. They are class I evidence, guideline-directed medical therapy in heart failure irrespective of ejection fraction or diabetes mellitus. There are several assumptions about the mechanism of their action, but the exact mechanism has not yet been determined. Every doctor should be familiar with these new drugs for the implementation of their uses and better recognize and limit side effects.
Publisher: MIT University Skopje
Relation: International Journal of Recent Research in Arts and Sciences
Identifier: oai:repository.ukim.mk:20.500.12188/29864
Identifier: http://hdl.handle.net/20.500.12188/29864